Cited by 34Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

Archer, Trevor, Kostrzewa, Richard M., Beninger, Richard J., Palomo, Tomas·2011·Neurotoxicity Research

DOI 10.1007/s12640-010-9190-2

Open this paper in CoChat — free account

Abstract

The notion of staging in the neurodegenerative disorders is modulated by the constant and progressive loss of several aspects of brain structural integrity, circuitry, and neuronal processes. These destructive processes eventually remove individuals' abilities to perform at sufficient and necessary functional capacity at several levels of disease severity. The classification of (a) patients on the basis of diagnosis, risk prognosis, and intervention outcome, forms the basis of clinical staging, and (b) laboratory animals on the basis of animal model of brain disorder, extent of insult, and dysfunctional expression, provides the components for the clinical staging and preclinical staging, respectively, expressing associated epidemiological, biological, and genetic characteristics. The major focus of clinical staging in the present account stems from the fundamental notions of Braak staging as they describe the course and eventual prognosis for Alzheimer's disease, Lewy Body dementia, and Parkinson's disease. Mild cognitive impairment, which expresses the decline in episodic and semantic memory performance below the age-adjusted normal range without marked loss of global cognition or activities of daily living, and the applications of longitudinal magnetic resonance imaging, major instruments for the monitoring of either disease progression in dementia, present important challenges for staging concepts. Although Braak notions present the essential basis for further developments, current staging conceptualizations seem inadequate to comply with the massive influx of information dealing with neurodegenerative processes in brain, advanced both under clinical realities, and discoveries in the laboratory setting. The contributions of various biomarkers of disease progression, e.g., amyloid precursor protein, and neurotransmitter system imbalances, e.g., dopamine receptor supersensitivity and interactive propensities, await their incorporation into the existing staging models thereby underlining the ongoing, dynamic feature of the staging of brain disorders.

Integrity signals

Registry

Crossref · 10.1007/s12640-010-9190-2

Cites

355 of 355 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment.
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
The Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282
Navigation-related structural change in the hippocampi of taxi drivers
Maguire, E. A., Gadian, D. G., Johnsrude, I. S., Good, C. D., Ashburner, J., Frackowiak, R. S. J., & Frith, C. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070039597 · Cited by 3,225
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Goetz, C. G., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C. E., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,360
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Toga, A. W., & Beckett, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,493
Patients with hippocampal amnesia cannot imagine new experiences
Hassabis, D., Kumaran, D., Vann, S. D., & Maguire, E. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610561104 · Cited by 1,414
Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter
Raz, N. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.3.268 · Cited by 1,292
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 2×
“Morphological changes in Alzheimer’s disease are much more severe: widely decreased grey matter volumes in the medial temporal structures, hippocampal formation, entorhinal cortex, and parahippocampal gyrus ranging from mild to advanced stages (Bouras et al. 1993; Kemper 1994; Terry et al. 1981; West et al. 1994) 214…”
Background
Cerebral Asymmetry and the Effects of Sex and Handedness on Brain Structure: A Voxel-Based Morphometric Analysis of 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0857 · Cited by 1,222
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176
Fiber Pathways of the Brain
Schmahmann, J. D., & Pandya, D. N. (2006) · doi:10.1093/acprof:oso/9780195104233.001.0001 · Cited by 1,157
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.
Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987
Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease
Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 938
Mild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935
London taxi drivers and bus drivers: A structural MRI and neuropsychological analysis
Maguire, E. A., Woollett, K., & Spiers, H. J. (2006) · Hippocampus · doi:10.1002/hipo.20233 · Cited by 918
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910
Parkinsonism
Hoehn, M. M. M., & Yahr, M. D. (1998) · Neurology · doi:10.1212/wnl.50.2.318 · Cited by 873
Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI
Wang, L. Y., Zang, Y., Yong He, A., Liang, M., Zhang, X., Tian, L., Wu, T., Jiang, T., & Li, K. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.12.033 · Cited by 867
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827
Parkinson’s Disease and Movement Disorders
Tn, M., & Bhattacharyya, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 802
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
Dementia with Lewy bodies.
McKeith, I. G. (2004) · Europe PMC (PubMed Central) · Cited by 756
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Landau, S. M., Harvey, D., Madison, C. M., Koeppe, R. A., Reiman, E. M., Foster, N. L., Weiner, M. W., & Jagust, W. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.002 · Cited by 750
Hippocampal and entorhinal atrophy in mild cognitive impairment
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., Santi, S. D., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 749
The Episodic Memory System: Neurocircuitry and Disorders
Dickerson, B. C., & Eichenbaum, H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.126 · Cited by 740
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727
In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease
Baron, J., Chételat, G., Desgranges, B., Perchey, G., Landeau, B., Sayette, V. D. L., & Eustache, F. (2001) · NeuroImage · doi:10.1006/nimg.2001.0848 · Cited by 699
Pathoanatomy of Parkinson’s disease
Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643
Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630
Corticodentatonigral Degeneration With Neuronal Achromasia
Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470310034003 · Cited by 627
Functional Alterations in Memory Networks in Early Alzheimer’s Disease
Sperling, R. A., Dickerson, B. C., Pihlajamaki, M. M., Vannini, P., LaViolette, P. S., Vitolo, O. V., Hedden, T., Becker, J. A., Rentz, D. M., Selkoe, D. J., et al. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8109-7 · Cited by 617
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
Karas, G. B., Scheltens, P., Rombouts, S. A. R. B., Visser, P. J., van Schijndel, R. A., Fox, N. C., & Barkhof, F. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.006 · Cited by 613
The cholinergic system and Parkinson disease
Bohnen, N. I., & Albin, R. L. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.048 · Cited by 607
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607
Mild cognitive impairment
Chételat, G., Desgranges, B., Sayette, V. D. L., Viader, F., Eustache, F., & Baron, J. (2003) · Neurology · doi:10.1212/01.wnl.0000055847.17752.e6 · Cited by 606
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
Hurtig, H. I., Trojanowski, J. Q., Galvin, J. E., Ewbank, D., Schmidt, M. L., Lee, V. M. Y., Clark, C., Glosser, G., Stern, M. B., Gollomp, S. M., et al. (2000) · Neurology · doi:10.1212/wnl.54.10.1916 · Cited by 604
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 602
Medial temporal lobe function and structure in mild cognitive impairment
Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R., Greve, D. N., Dale, A. M., Stern, C. E., Blacker, D., Albert, M., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20163 · Cited by 579
Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies
Kramer, M. L., & Schulz-Schaeffer, W. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-06.2007 · Cited by 571
Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak, H., Rüb, U., Steur, E. N. H. J., Tredici, K. D., & de Vos, R. A. I. (2005) · Neurology · doi:10.1212/01.wnl.0000158422.41380.82 · Cited by 566
Biochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 563
The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
Wakabayashi, K., Tanji, K., Mori, F., & Takahashi, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00803.x · Cited by 544
Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies
Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532
Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia
Boeve, B. F., Lang, A. E., & Litvan, I. (2003) · Annals of Neurology · doi:10.1002/ana.10570 · Cited by 526
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study
Chételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.-C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.015 · Cited by 526
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease
Zhang, Y., Schuff, N. W., Jahng, G., Bayne, W., Mori, S., Schad, L. R., Mueller, S. G., Du, A., Kramer, J. H., Yaffe, K. S., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000250326.77323.01 · Cited by 513
The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
Shulman, L. M., Gruber-Baldini, A. L., Anderson, K. E., Fishman, P. S., Reich, S. G., & Weiner, W. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.295 · Cited by 494
Advances in the early detection of Alzheimer's disease
Nestor, P. J., Scheltens, P., & Hodges, J. R. (2004) · Nature Medicine · doi:10.1038/nrn1433 · Cited by 480
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease
Morris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476
Synucleinopathies
Galvin, J. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.186 · Cited by 473
Structural Asymmetries in the Human Brain: a Voxel-based Statistical Analysis of 142 MRI Scans
Watkins, K. E. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.9.868 · Cited by 471
The use of PET in Alzheimer disease
Nordberg, A. K., Rinne, J. O., Kadir, A., & Långström, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.217 · Cited by 467
Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe Consortium
Alafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467
Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP
Josephs, K. A., Petersen, R. C., Knopman, D. S., Boeve, B. F., Whitwell, J. L., Duffy, J. R., Parisi, J. E., & Dickson, D. W. (2006) · Neurology · doi:10.1212/01.wnl.0000191307.69661.c3 · Cited by 458
Evolution in the Conceptualization of Dementia and Alzheimer’s Disease: Greco-Roman Period to the 1960s
Berchtold, N. C., & Cotman, C. W. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00052-9 · Cited by 456
Voxel-Based Morphometry
Ashburner, J., & Friston, K. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012372560-8/50007-3 · Cited by 445
Predictors of progression from mild cognitive impairment to Alzheimer disease
Palmer, K., Berger, A., Monastero, R., Winblad, B. G., Bäckman, L., & Fratiglioni, L. (2007) · Neurology · doi:10.1212/01.wnl.0000260968.92345.3f · Cited by 436
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression
Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., & De Strooper, B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.009 · Cited by 436
Pathological correlates of dementia in a longitudinal, population‐based sample of aging
Sonnen, J. A., Larson, E. B., Crane, P. K., Haneuse, S., Li, G., Schellenberg, G. D., Craft, S., Leverenz, J. B., & Montine, T. J. (2007) · Annals of Neurology · doi:10.1002/ana.21208 · Cited by 432
The cell biology of rabies virus: using stealth to reach the brain
Schnell, M. J., McGettigan, J. P., Wirblich, C., & Papaneri, A. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2260 · Cited by 409
Neuropathology of Autonomic Nervous System in Parkinson's Disease
Wakabayashi, K., & Takahashi, H. (2008) · European Neurology · doi:10.1159/000113469 · Cited by 407
Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment
Chételat, G., Desgranges, B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J. (2002) · NeuroReport · doi:10.1097/00001756-200210280-00022 · Cited by 405
Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies
Ishizawa, T., Mattila, P. M., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 402
Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia
Jicha, G. A., Parisi, J. E., Dickson, D. W., Johnson, K., Cha, R., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., Knopman, D. S., Braak, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.674 · Cited by 399
Echogenicity of the Substantia Nigra
Berg, D., Roggendorf, W., Schroeder, U., Klein, R., Tatschner, T., Benz, P. M., Tucha, O. M., Preier, M., Lange, K. W., Reiners, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.999 · Cited by 381
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
Parkkinen, L., Pirttilä, T., & Alafuzoff, I. I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0346-6 · Cited by 377
MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
Whitwell, J. L., Josephs, K. A., Murray, M. E., Kantarci, K., Przybelski, S. A., Weigand, S. D., Vemuri, P., Senjem, M. L., Parisi, J. E., Knopman, D. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324924.91351.7d · Cited by 376
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease
Villain, N., Desgranges, B., Viader, F., de la Sayette, V., Mezenge, F., Landeau, B., Baron, J.-C., Eustache, F., & Chetelat, G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1392-08.2008 · Cited by 366
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease
Mattila, P. M., Rinne, J. O., Helenius, H. Y. M., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 363
Clinical Neurology of Aging
(2010) · Oxford University Press eBooks · doi:10.1093/med/9780195369298.001.0001 · Cited by 360
[ 123 I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression
MAREK, K. L., Innis, R. B., van Dyck, C. H., Fussell, B., Early, M., Eberly, S. W., Oakes, D., & Seibyl, J. P. (2001) · Neurology · doi:10.1212/wnl.57.11.2089 · Cited by 348
α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
Bloch, A., Probst, A., Bissig, H., Adams, H., & Tolnay, M. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00727.x · Cited by 337
Navigation around London by a taxi driver with bilateral hippocampal lesions
Maguire, E. A., Nannery, R., & Spiers, H. J. (2006) · Brain · doi:10.1093/brain/awl286 · Cited by 335
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD
deToledo‐Morrell, L., Stoub, T. R., Bulgakova, M., Wilson, R. S., Bennett, D. A., Leurgans, S. E., Wuu, J., & Turner, D. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.007 · Cited by 330
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. I. (2004) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 328
Pattern of brain destruction in Parkinson's and Alzheimer's diseases
Braak, H., Braak, E., Yilmazer‐Hanke, D., de Vos, R. A. I., Jansen, E. N. H., & Böhl, J. (1996) · Journal of Neural Transmission · doi:10.1007/bf01276421 · Cited by 326
Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein
Uversky, V. N., & Eliezer, D. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789351921 · Cited by 325
The cortical signature of prodromal AD
Bakkour, A., Morris, J. C., & Dickerson, B. C. (2008) · Neurology · doi:10.1212/01.wnl.0000340981.97664.2f · Cited by 321
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Ivnik, R. J., Vemuri, P., Gunter, J. L., Senjem, M. L., Shiung, M. M., Boeve, B. F., Knopman, D. S., et al. (2009) · Brain · doi:10.1093/brain/awp232 · Cited by 320
A systematic review of the effects of antipsychotic drugs on brain volume
Moncrieff, J., & Leo, J. (2010) · Psychological Medicine · doi:10.1017/s0033291709992297 · Cited by 312
Brain size and grey matter volume in the healthy human brain
ders, E. L., Steinmetz, H., & Jäncke, L. (2002) · Neuroreport · doi:10.1097/00001756-200212030-00040 · Cited by 312
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
Olichney, J., Galasko, D. R., Salmon, D. P., Hofstetter, C. R., Hansen, L. A., Katzman, R., & Thal, L. J. (1998) · Neurology · doi:10.1212/wnl.51.2.351 · Cited by 306
Cortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 298
Neuroanatomy and Pathology of Sporadic Parkinson's Disease
Braak, H., & Tredici, K. D. (2008) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-540-79850-7 · Cited by 297
Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity
Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [ 11 C]PiB
Resnick, S. M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D. P., Dannals, R. F., Mathis, C. A., Klunk, W. E., Ferrucci, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d3e3e9 · Cited by 288
Clinical Neurology of Aging
Poser, C. M. (1995) · JAMA · doi:10.1001/jama.1995.03520280102058 · Cited by 284
A common functional brain network for autobiographical, episodic, and semantic memory retrieval
Burianova, H., McIntosh, A. R., & Grady, C. L. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.08.066 · Cited by 283
Low sensitivity in clinical diagnoses of dementia with Lewy bodies
Nelson, P. T., Jicha, G. A., Kryscio, R. J., Abner, E. L., Schmitt, F. A., Cooper, G. E., Xu, L., Smith, C. D., & Markesbery, W. R. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5324-y · Cited by 279
Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases
Iwanaga, K., Wakabayashi, K., Yoshimoto, M., Tomita, I., Satoh, H., Takashima, H., Satoh, A., Seto, M., Tsujihata, M., & Takahashi, H. (1999) · Neurology · doi:10.1212/wnl.52.6.1269 · Cited by 277
Volume reduction of the entorhinal cortex in subjective memory impairment
Jessen, F., Feyen, L., Freymann, K., Tepest, R., Maier, W., Heun, R., Schild, H. H., & Scheef, L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.010 · Cited by 276
Progression of motor impairment and disability in Parkinson disease
Alves, G. W., Wentzel‐Larsen, T., Aarsland, D., & Larsen, J. P. (2005) · Neurology · doi:10.1212/01.wnl.0000183359.50822.f2 · Cited by 270
Antidepressant actions of the exercise-regulated gene VGF
Hunsberger, J. G., Newton, S. S., Bennett, A., Duman, C. H., Russell, D., Salton, S. R., & Duman, R. S. (2007) · Nature Medicine · doi:10.1038/nm1669 · Cited by 270
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Chetelat, G. (2003) · Brain · doi:10.1093/brain/awg196 · Cited by 264
SPECT perfusion imaging in the diagnosis of Alzheimer’s disease
Jagust, W., Thisted, R. A., Devous, M. D., Heertum, R. V., Mayberg, H. S., Jobst, K., Smith, A. D., & Borys, N. (2001) · Neurology · doi:10.1212/wnl.56.7.950 · Cited by 254
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 253
A 10‐item smell identification scale related to risk for Alzheimer's disease
Tabert, M. H., Liu, X., Doty, R. L., Serby, M., Zamora, D., Pelton, G. H., Marder, K. S., Albers, M. W., Stern, Y., & Devanand, D. P. (2005) · Annals of Neurology · doi:10.1002/ana.20533 · Cited by 250
Patterns and stages of α-synucleinopathy
ZACCAI, J. H., Brayne, C., McKeith, I. G., Matthews, F. E., & Ince, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000306697.48738.b6 · Cited by 249
The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg, L. T., Rüb, U., Ferretti, R. E. L., Nitríni, R., Farfel, J. M., Polichiso, L., Gierga, K., Jacob‐Filho, W., Heinsen, H., & Brazilian Brain Bank Study Group (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00997.x · Cited by 247
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Jellinger, K. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.006 · Cited by 247
Diffusion tensor imaging in Alzheimer’s disease and mild cognitive impairment.
Stebbins, G. T., & Murphy, C. M. (2009) · Behavioural Neurology · doi:10.1155/2009/915041 · Cited by 245
Exacerbated physical fatigue and mental fatigue in Parkinson's disease
Lou, J., Kearns, G. L., Oken, B., Sexton, G. J., & Nutt, J. G. (2001) · Movement Disorders · doi:10.1002/mds.1042 · Cited by 244
Twenty years on
Shepherd, M. A. (1990) · Psychological Medicine · doi:10.1017/s0033291700013167 · Cited by 242
Intrinsic disorder in proteins associated with neurodegenerative diseases
Vladimir, N. (2009) · Frontiers in bioscience · doi:10.2741/3594 · Cited by 241
A critical reappraisal of current staging of Lewy-related pathology in human brain
Jellinger, K. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0406-y · Cited by 240
Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease
Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0705-2 · Cited by 237
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
Beach, T. G., White, C. L., Hladik, C. L., Sabbagh, M. N., Connor, D. J., Shill, H. A., Sue, L. I., Sasse, J., Bachalakuri, J., Henry-Watson, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0450-7 · Cited by 237
Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Markesbery, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1220 · Cited by 236
Memory and mental status correlates of modified Braak staging
Grober, E. H., Dickson, D. W., Sliwinski, M. J., Herman Buschke, L., Katz, M., Crystal, H., & Lipton, R. B. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00063-9 · Cited by 235
A voxel-based approach to gray matter asymmetries
Eileen Luders, A., Christian Gaser, B., Jäncke, L., & Gottfried Schlaug, A. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.032 · Cited by 234
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
Bourgeat, P., Chételat, G., Villemagne, V. L., Fripp, J., Raniga, P., Pike, K., Acosta, O., Szoeke, C., Ourselin, S., Ames, D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c918b5 · Cited by 220
Mild Cognitive Impairment in the General Population: Occurrence and Progression to Alzheimer Disease
Palmer, K., Bäckman, L., Winblad, B. G., & Fratiglioni, L. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181753a64 · Cited by 219
A voxel based morphometry study on mild cognitive impairment
Pennanen, C. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035600 · Cited by 218
Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease
Leyhe, T., Müller, S., Milian, M., Eschweiler, G. W., & Saur, R. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.04.018 · Cited by 212
Lewy Body Pathology in Normal Elderly Subjects
Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ac10a7 · Cited by 210
Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment.
Stebbins, G. T., & Murphy, C. M. (2009) · PubMed · doi:10.3233/ben-2009-0234 · Cited by 210
Voxel-based detection of white matter abnormalities in mild Alzheimer disease
Xie, S., Xiao, J., Gong, G., Zang, Y., Wang, Y., Wu, H., & Jiang, X. X. (2006) · Neurology · doi:10.1212/01.wnl.0000219625.77625.aa · Cited by 208
Brain size and grey matter volume in the healthy human brain.
Lüders, E., Steinmetz, H., & Jäncke, L. (2002) · PubMed · doi:10.1097/01.wnr.0000049603.85580.da · Cited by 208
Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?
Aarsland, D., Ballard, C. G., & Halliday, G. M. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267470 · Cited by 208
Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
Cairns, N. J., Ikonomović, M. D., Benzinger, T. L. S., Storandt, M., Fagan, A. M., Shah, A. R., Taylor‐Reinwald, L., Carter, D. R., Felton, A., Holtzman, D. M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.279 · Cited by 205
Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study
Chan, D., Janssen, J. C., Whitwell, J. L., Watt, H., Jenkins, R., Frost, C. D., Rossor, M. N., & Fox, N. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14469-8 · Cited by 204
Does Alzheimer's disease begin in the brainstem?
Simic, G., Stanic, G., Mladinov, M., Jovanov‐Milosevic, N., Kostovic, I., & Hof, P. R. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01038.x · Cited by 204
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease
Bradley, K. M. (2002) · Brain · doi:10.1093/brain/awf185 · Cited by 203
α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study
Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0725-y · Cited by 201
Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study
Rémy, F., Mirrashed, F., Campbell, B. I., & Richter, W. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.10.045 · Cited by 200
Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease
Tang, C. C., Poston, K. L., DHAWAN, V. M., & Eidelberg, D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4188-09.2010 · Cited by 200
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo, C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.852 · Cited by 200
Nigral and extranigral pathology in Parkinson's disease.
Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198
Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease
Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., & Avison, M. J. (1999) · Neurology · doi:10.1212/wnl.53.7.1391 · Cited by 197
Formation and development of Lewy pathology: a critical update
Jellinger, K. A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5243-y · Cited by 195
Episodic and semantic memory in mild cognitive impairment
Dudas, R. B., Clague, F., Thompson, S., Graham, K. S., & Hodges, J. R. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.12.005 · Cited by 190
Volume Loss of the Medial Temporal Lobe Structures in Subjective Memory Impairment
Striepens, N., Scheef, L., Wind, A., Popp, J., Spottke, A. E., Cooper‐Mahkorn, D., Suliman, H., Wagner, M., Schild, H. H., & Jessen, F. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000264630 · Cited by 189
The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
DAVIS, K. E. (1992) · PubMed · Cited by 188
Pathology associated with sporadic Parkinson’s disease — where does it end?
Braak, H., Müller, C. M., Rüb, U., Ackermann, H., Bratzke, H., de Vos, R. A. I., & Tredici, K. D. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_15 · Cited by 182
Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process?
Ohnishi, T., Matsuda, H., Tabira, T., Asada, T., & Uno, M. (2001) · PubMed Central · Cited by 181
Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease
Rasgon, N., Kenna, H. A., Wroolie, T., Kelley, R. G., Silverman, D. H. S., Brooks, J. O., Williams, K. E., Powers, B. N., Hallmayer, J. F., & Reiss, A. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.005 · Cited by 180
Neurofilament inclusion body disease: a new proteinopathy?
Josephs, K. A., Holton, J. L., Rossor, M. N., Brændgaard, H., Ozawa, T., Fox, N. C., Petersen, R. C., Pearl, G. S., Ganguly, M., Rosa‐Neto, P., et al. (2003) · Brain · doi:10.1093/brain/awg231 · Cited by 176
Naming of objects, faces and buildings in mild cognitive impairment
Ahmed, S., Arnold, R. J., Thompson, S., Graham, K. S., & Hodges, J. R. (2007) · Cortex · doi:10.1016/j.cortex.2007.02.002 · Cited by 175
Atrophy rates accelerate in amnestic mild cognitive impairment
Jack, C. R., Weigand, S. D., Shiung, M. M., Przybelski, S. A., O’Brien, P. C., Gunter, J. L., Knopman, D. S., Boeve, B. F., Smith, G. E., & Petersen, R. C. (2007) · Neurology · doi:10.1212/01.wnl.0000281688.77598.35 · Cited by 175
The nature of lexico-semantic processing deficits in mild cognitive impairment
Duong, A., Whitehead, V., Hanratty, K., & Chertkow, H. M. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.01.034 · Cited by 175
Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage
Vemuri, P., Whitwell, J. L., Kantarci, K., Josephs, K. A., Parisi, J. E., Shiung, M. S., Knopman, D. S., Boeve, B. F., Petersen, R. C., Dickson, D. W., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.012 · Cited by 172
Multivariate network analysis of fiber tract integrity in Alzheimer’s disease
Teipel, S. J., Stahl, R., Dietrich, O., Schoenberg, S. O., Perneczky, R., Bokde, A. L. W., Reiser, M. F., Möller, H., & Hampel, H. J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.07.047 · Cited by 169
Measurements of the Amygdala and Hippocampus in Pathologically Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
Barnes, J., Whitwell, J. L., Frost, C. D., Josephs, K. A., Rossor, M. N., & Fox, N. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1434 · Cited by 164
FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment
Chételat, G., Eustache, F., Viader, F., Sayette, V. D. L., Pèlerin, A., Mézenge, F., Hannequin, D., Dupuy, B., Baron, J., & Desgranges, B. (2005) · Neurocase · doi:10.1080/13554790490896938 · Cited by 164
The brain in the age of old: The hippocampal formation is targeted differentially by diseases of late life
Wu, W. E., Brickman, A. M., Luchsinger, J. A., Ferrazzano, P. A., Pichiule, P., Yoshita, M., Brown, T. R., DeCarli, C. S., Barnes, C. A., Mayeux, R. P., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21557 · Cited by 163
Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease.
Jobst, K. A., Smith, A. D., Barker, C. S., Wear, A., King, E. M., Smith, A. D., Anslow, P., Molyneux, A., SHEPSTONE, B. J., & Soper, N. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.190 · Cited by 163
Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease
Miklossy, J., Khalili, K., Gern, L., Ericson, R. L., Darekar, P., Bolle, L., Hurlimann, J., & Paster, B. J. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6608 · Cited by 163
Brain structural alterations before mild cognitive impairment
Smith, C. D., Chebrolu, H., Wekstein, D. R., Schmitt, F. A., Jicha, G. A., Cooper, G., & Markesbery, W. R. (2007) · Neurology · doi:10.1212/01.wnl.0000259542.54830.34 · Cited by 161
Enhanced frontal function in Parkinson's disease
Cools, R., Miyakawa, A., Sheridan, M. A., & D’Esposito, M. (2009) · Brain · doi:10.1093/brain/awp301 · Cited by 161
Cognitive and affective disturbances following focal cerebellar damage in adults: A neuropsychological and SPECT study
Baillieux, H., Smet, H. J. D., Dobbeleir, A. A., Paquier, P. F., Deyn, P. P. D., & Mariën, P. (2009) · Cortex · doi:10.1016/j.cortex.2009.09.002 · Cited by 160
RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy‐Related Pathology in the Dementia Patient
Leverenz, J. B., Hamilton, R. L., Tsuang, D. W., Schantz, A. M., Vavrek, D. A., Larson, E. B., Kukull, W. A., López, O. L., Galasko, D. R., Masliah, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00117.x · Cited by 159
Biomarkers for Alzheimer’s disease and other forms of dementia: Clinical needs, limitations and future aspects
Cedazo-Mínguez, Á., & Winblad, B. G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.008 · Cited by 159
Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.
Matsuda, H., Kitayama, N., Ohnishi, T., Asada, T., Nakano, S., Sakamoto, S., Imabayashi, E., & Katoh, A. (2002) · PubMed · Cited by 157
Episodic memory impairment in patients with Alzheimer’s disease is correlated with entorhinal cortex atrophy
Paola, M., Macaluso, E., Carlesimo, G. A., Tomaiuolo, F., Worsley, K. J., Fadda, L., & Caltagirone, C. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0435-1 · Cited by 155
Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease
Pievani, M., Agosta, F., Pagani, E., Canu, E., Sala, S., Absinta, M., Geroldi, C., Ganzola, R., Frisoni, G. B., & Filippi, M. (2010) · Human Brain Mapping · doi:10.1002/hbm.20978 · Cited by 152
Rapidly Progressive Neurodegenerative Dementias
Josephs, K. A., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., Crum, B. A., Giannini, C., & Petersen, R. C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.534 · Cited by 152
Apathy and Depression in Parkinson Disease
Oguru, M., Tachibana, H., Toda, K., Okuda, B., & Oka, N. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709351834 · Cited by 151
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients
Martorana, A., Mori, F., Esposito, Z., Kusayanagi, H., Monteleone, F., Codecà, C., Sancesario, G., Bernardi, G., & Koch, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.60 · Cited by 148
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease
Fouquet, M., Desgranges, B., Landeau, B., Duchesnay, É., Mézenge, F., Sayette, V. D. L., Viader, F., Baron, J., Eustache, F., & Chételat, G. (2009) · Brain · doi:10.1093/brain/awp132 · Cited by 148
Trajectories of brain loss in aging and the development of cognitive impairment
Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000280577.43413.d9 · Cited by 144
Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry
Chételat, G., Fouquet, M., Kalpouzos, G., Denghien, I., De la Sayette, V., Viader, F., Mézenge, F., Landeau, B., Baron, J. C., Eustache, F., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.11.037 · Cited by 143
Structural insights on physiological functions and pathological effects of ±‐synuclein
Bisaglia, M., Mammi, S., & Bubacco, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-119784 · Cited by 143
Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes
Bouras, C., Hof, P. R., & Morrison, J. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90305-5 · Cited by 142
Effect of age at onset on progression and mortality in Parkinson's disease
Diamond, S. G., Markham, C. H., Hoehn, M. M. M., MCDOWELL, F. H., & Muenter, M. D. (1989) · Neurology · doi:10.1212/wnl.39.9.1187 · Cited by 141
Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study
Mori, E., Yoneda, Y., Yamashita, H., Hirono, N., Ikeda, M., & Yamadori, A. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.2.214 · Cited by 140
Non-motor extranigral signs and symptoms in Parkinson's disease
Wolters, E. C. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70770-9 · Cited by 139
Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease
Basso, M. R., Yang, J., Warren, L. H., MacAvoy, M. G., Varma, P., Bronen, R. A., & van Dyck, C. H. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.01.007 · Cited by 137
Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profile
Alladi, S., Arnold, R. J., Mitchell, J., Nestor, P. J., & Hodges, J. R. (2006) · Psychological Medicine · doi:10.1017/s0033291705006744 · Cited by 137
Diagnostic staging of Parkinson?s disease: conceptual aspects
Przuntek, H., M�ller, T., & Riederer, P. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0102-y · Cited by 137
Rating impairment and disability in Parkinson's disease: Evaluation of the unified Parkinson's disease rating scale
van Hilten, J. J., van der Zwan, A. D., Zwinderman, A. H., & Roos, R. A. C. (1994) · Movement Disorders · doi:10.1002/mds.870090113 · Cited by 136
Spontaneous mentalizing during an interactive real world task: An fMRI study
Spiers, H. J., & Maguire, E. A. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.03.028 · Cited by 136

Research works printed but not linked: 2

Raz N (1996) Neuroanatomy of aging brain: evidence from structural MRI. In: Bigler ED (ed) Neuroimaging II: clinical application. Plenum Press, New York, pp 273–300
Smith CD (2007) Mild cognition impairment is too late: the case for presymptomatic detection and treatment for Alzheimer’s disease. Cogn Sci 3:127–177

Sorted by citations

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial
Henskens, M., Nauta, I. M., van Eekeren, M. C. A., & Scherder, E. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000491818 · Cited by 122
Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?
Carlino, D., Vanna, M. D., & Tongiorgi, E. (2012) · The Neuroscientist · doi:10.1177/1073858412469444 · Cited by 117
Physical exercise alleviates debilities of normal aging and Alzheimer’s disease
Archer, T. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01412.x · Cited by 112
Self-citation
Peripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis
Kozin, S. A., Cheglakov, I. B., Ovsepyan, A. A., Telegin, G. B., Tsvetkov, P. O., Лисица, А. В., & Makarov, A. А. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9399-y · Cited by 97

See all 34

Authors: Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T.
Affiliations: University of Gothenburg (SE)
East Tennessee State University (US)
Queen's University (CA)
Corresponding author: Archer, Trevor
ORCID: Kostrzewa, Richard M.
Venue: Neurotoxicity Research
Publisher: Springer Science and Business Media LLC
Published: 2010-04-15
Volume: 19
Issue: 2
Pages: 211-234
ISSN: 1029-8428 (ISSN-L)
1476-3524
DOI: 10.1007/s12640-010-9190-2
OpenAlex: W2001174540
Cited by: 34
References: 355
Citations by year: 2026: 3 · 2023: 3 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 8 · 2014: 3 · 2013: 4 · 2012: 3
FWCI: 2.15
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Neurotoxicity Research (publishedVersion)
PubMed (publishedVersion)
Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: Braak staging, Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, mild cognitive impairment, disease progression biomarkers, amyloid precursor protein, dopamine receptor supersensitivity, longitudinal MRI, animal models of neurodegeneration, brain structural integrity
MeSH terms: Animals, Humans, Biomarkers, Disease Progression, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks